InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Gottschalk Adrian, Chief Executive Officer. Director active across 1 company, notably Foghorn Therapeutics Inc.. Cumulatively, 11 filings have been published. History available since 20 August 2021. The latest transaction was filed on 9 April 2026 (Don). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
GOTTSCHALK ADRIAN is Directeur Général and Chief Executive Officer at Foghorn Therapeutics Inc. He has 11 filings in total, and across the sampled recent filings the most frequent transaction nature is Don, with a period ranging from 2021-08-23 to 2026-04-13.